Earnings
CTXR
1.730
+1.17%
0.020
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-09-30
13.86M
--
--
--
--
--
0.00
--
--
--
122.24K
--
13.98M
987.78K
--
--
--
9.35M
19.40M
--
57.09K
29.79M
43.77M
--
1.86M
172.97K
--
--
--
--
--
2.07M
--
--
--
--
4.10M
164.58K
--
--
4.99M
855.47K
6.01M
10.10M
55.58K
104.21M
-70.59M
--
--
--
33.67M
33.67M
43.77M
FY 2019-09-30
7.89M
--
--
--
--
--
0.00
--
--
--
48.11K
--
7.94M
590.00
--
--
--
9.35M
19.40M
--
57.09K
28.80M
36.75M
--
2.71M
172.97K
--
--
--
--
--
1.72M
--
--
--
0.00
4.61M
0.00
--
--
4.99M
--
4.99M
9.59M
28.93K
80.17M
-53.05M
--
--
--
27.15M
27.15M
36.75M
FY 2018-09-30
9.18M
--
--
--
--
--
818.34K
--
--
--
57.73K
--
10.06M
1480.00
--
--
--
1.59M
19.40M
--
2170.00
20.99M
31.05M
--
1.57M
172.97K
--
--
--
--
--
1.44M
--
--
--
0.00
3.18M
0.00
--
--
--
--
0.00
3.18M
16.20K
68.11M
-40.26M
--
--
--
27.87M
27.87M
31.05M
FY 2017-09-30
3.20M
--
--
--
--
--
0.00
--
--
--
220.25K
--
3.42M
3240.00
--
--
--
1.59M
19.40M
--
2170.00
20.99M
24.42M
--
602.43K
172.97K
--
--
--
--
--
1.67M
--
--
--
27.64K
2.47M
0.00
--
--
--
--
0.00
2.47M
8350.00
49.66M
-27.72M
--
--
--
21.95M
21.95M
24.42M
FY 2016-09-30
294.35K
--
--
--
--
--
0.00
--
--
--
598.48K
--
892.84K
3740.00
--
--
--
1.59M
19.40M
--
66.97K
21.06M
21.95M
--
909.16K
672.97K
--
--
--
--
--
1.89M
--
--
--
1.71M
5.18M
0.00
--
--
--
--
0.00
5.18M
73.14K
34.03M
-17.34M
--
--
--
16.77M
16.77M
21.95M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out CTXR latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Citius Pharmaceuticals Inc recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.